EGFR and lung adenocarcinoma: Here, we report a female patient with advanced lung adenocarcinoma (LUAD), carrying a rare mutation of <i>EGFR</i> Exon19 E746_L747delinsIP, who was administered first-generation EGFR-TKIs as the first-line treatment.